HONG KONG – Sinovac Biotech Ltd., China's leading vaccine maker, is in the midst of a go-private transaction that has morphed into a heated bidding war.

HONG KONG – China has seen a huge spike in patent applications, many of which are for pharmaceutical products. However, regulatory agencies such as the CFDA have yet to adapt to the changing patent landscape and to cope with the rapid surge.

HONG KONG – China has seen a huge spike in patent applications, many of which are for pharmaceutical products. However, regulatory agencies such as the CFDA have yet to adapt to the changing patent landscape and to cope with the rapid surge.

HONG KONG – Cancer in China is on the rise, and so is the demand for innovative cancer treatments. Local and multinational drugmakers are racing to tap into the growing need for new and effective treatments.

HONG KONG – Cancer in China is on the rise, and so is the demand for innovative cancer treatments. Local and multinational drugmakers are racing to tap into the growing need for new and effective treatments.